Venture Life Share Discussion Threads

[big7ime] 02/8/2020 15:49

I see it as unshackling itself from being a niche operator to a more mainstream offering. There are jobs being advertised on LinkedIn and they seen highly confident that this will be a transformative opportunity
Should see £3 pretty quickly I think.

[valhamos] 30/7/2020 20:20

Strong results last night from Lam Research - LRCX (a comparison entry) with continuing recovery in the memory sector for wafer fabrication equipment spend. Also good results from Skyworks - SKWS so the US reporting season has gone well "despite Covid". I'd include Intel in that but it was sold off after announcing a further delay for its 7nms CPUs - I've had a nibble as its only on a P/E of 10 and I reckon it will bounce back at some point.

[valhamos] 29/7/2020 13:32

Yes I was on the call, though missed some of the earlier slides. A lot for me to think through in terms of the trend to cloud based telephony and replacing location based PBX and still not sure how much of the cake will fall to LOOP as opposed to MSFT. What are your thoughts on the presentation?

Edit: just bought a few more

[big7ime] 29/7/2020 13:08

Excellent news Val, did you watch the presentation?

[valhamos] 29/7/2020 12:13

I guess the announcement from LOOP today answers my query from last week about what the high levels of development expenditure were for. Building Direct Routing within Microsoft Teams into their LoopUp product should increase their addressable market.

[piedro] 29/7/2020 10:06

FWIW,

Four companies whose shares soared during the pandemic
BYOT, ERGO, NET and FLTA


TSTL did not make it

[jonut] 27/7/2020 20:19

Amazed that this board is now on the lower half my favourites page!

My PF has been washed aground for July apart from a rise of about 2.5% last week.

I've been accumulating cash over the last 2 months, maximum circa +33% mid July.

Have splurged a bit in the last 2 weeks or so on companies reporting revenues unaffected by the virus.

Not very exciting, but I can do without that for a while.

Safestore (SAFE)
Civitas (CSH)
RWS Holdings are now overweight
IG Group (IGG) revenues have boomed in the last quarter, although The share price hasn't. I bought when it dipped,
and today Kainos issued a very upbeat update giving an immediate 11.4% profit.


When those hardest hit, issue their updates showing revenues falling off a cliff, these should benefit.

All IMHO and DYOR.

Good luck to the regular contributors here, back to lurking for me.

[johnv] 27/7/2020 18:16

Are we going to fill that gap down to 74p

[rivaldo] 24/7/2020 12:06

Worth pasting here the conclusion to Cenkos' latest note, which hasn't been posted before and is worth reading:

"Investment thesis - Venture Life is having an exceptional year. For FY20E, we forecast c50% revenue growth, +100% adj EBITDA growth and adjusted EPS growth of 150%, while the strong balance sheet and access to low-rate Italian debt could, alone, support additive M&A opportunities. We believe the current P/E of 13.2x significantly undervalues the growth potential of the business. We believe our forecasts remain conservative and reiterate our Buy recommendation."

[tewkesbury] 22/7/2020 10:50

Pantheon Resources (PANR):

Currently 20p, immediate target 60p+ (3x bagger) (100p+ on opportunistic takeover).

PANR's recent Blytheway web chat. PANR shares could soon be 60p+ on the basis of what CEO Jay says (and more on an "opportunistic takeover").

7/7/2020
3 min 50 onwards:

[piedro] 21/7/2020 08:16

ERGO

Ergomed H1 2020 Trading Update
Trading materially ahead of expectations
Building on the robust performance reported at the beginning of the year, Ergomed had an excellent first half, with overall growth in revenue driven by continued demand for its services across the integrated business, despite the global Covid-19 pandemic. Ergomed now expects EBITDA for the year ending 31 December 2020 to be materially ahead of current market expectations

[rivaldo] 21/7/2020 07:46

I note from Alliance Pharma's trading statement today that Kelo-Cote sales for H1'20 did well - this should benefit VLG nicely going forward:

"Sales of Kelo-cote(TM) for the six months were up GBP1.1m at GBP14.2m (H1 2019: GBP13.1m)"

[croasdalelfc] 20/7/2020 08:44

I can't see DIsinplus in Asda yet? Is it for sale yet?

[rivaldo] 20/7/2020 07:56

Cheers EC. Too early in H2 for yet another upgrade - understandably Cenkos are being conservative, and will probably wait until a further trading update later in the year to upgrade further as necessary.

[effortless cool] 20/7/2020 07:49

Well, I got that wrong. Per Cenkos, this morning:

"Forecasts – We are maintaining a conservative perspective on FY20E, having upgraded our forecasts twice this year and reflecting the on-going COVID-19 pandemic. As such, we are leaving our forecasts unchanged at this time.

FY20E Outlook – We expect continued growth for H2/20E, with our current estimate suggesting +20% revenue growth. Clearly, unlike historic years, our forecasts suggest FY20E revenues will be H1 weighted, reflecting early pandemic demand for DISINPLUS, initial Chinese orders and our conservative view on the second half".

[effortless cool] 20/7/2020 07:27

An excellent update. £16.9m revenue in H1 versus a current broker forecast of £30.2m for FY 2020 must mean we are in for an upgrade, especially as VLG has previously shown a strong seasonal bias towards H2 in its Brands segment.

[rivaldo] 20/7/2020 07:18

Trading statement for H1 shows VLG firing on all cylinders, and innovation paying off via new sales of hand sanitiszer (including 1m units to Asda so far).

Plus news of two new distribution agreements since the year end:

"New long term exclusive distribution agreement signed in Spain for Procto-eze Plus

New long term exclusive distribution agreement signed in Israel on the Nail Fungal Pen, Wart Pen and Shoe Spray"

And most importantly, a specific statement that this growth is expected to continue in H2:



"Jerry Randall, CEO of Venture Life said , "There has been step change in the business in this first half of the year, with revenues increasing by 80% to GBP16.9 million, of which 65% is from organic growth alone. This is a remarkable achievement, amidst an extremely challenging backdrop of the COVID-19 pandemic; we have demonstrated agility both of our team and our business model, and this agility will provide us with a strong platform for future growth. Our newly created hand-sanitising brand DISINPLUS Ô has started well and generated meaningful revenues in H1 and, given the organic growth within the business, our Venture Life brands now represent 53% of revenues. Furthermore, we have seen strong sales in the UK and The Netherlands from the PharmaSource acquired products, as well as strong orders from our Chinese partner.

With our strong balance sheet we continue to explore additive M&A opportunities using our existing cash resources and available debt finance alone.

The first half has demonstrated the resilience and opportunity within our business, along with the strength and ingenuity of our team, in very difficult economic circumstances, and we remain confident that this will continue to be the case as we move into the second half of the year."

[hastings] 20/7/2020 07:15

Excellent TU this morning, very impressive organic growth in particular.

[valhamos] 17/7/2020 14:19

Big7 - thanks for that - had a nibble with LOOP first thing. Good geographic spread, with significant US sales a positive sign. There are quite high levels of capitalised development spend, and although I have defended this accounting treatment against those who suggest it should all be expensed, I would be happier if the company gave more information on how this improves the functionality of the product and expands its addressable market.

Still, needed a bit of added excitement after my portfolio, following the violent gyrations of the first 6 months, has gone to sleep in the last few weeks at break even for the year.

[big7ime] 16/7/2020 19:20

Bamboo I see you bought LOOP today also. Similar target I had in mind. Seems very cheap based on 12m ebitda for six mths.
Paul Scott’s piece is bullish

[apad] 16/7/2020 18:06

BOO

Kamani and Kane bought 5m and 2m shares at 214p.

apad

[farnesbarnes] 16/7/2020 13:28

I'm still waiting for this mouthwash report purporting a Covid 19 cure.